CN1051935C - Naoxuekang capsule for curing cerebrovascular disease and its production - Google Patents
Naoxuekang capsule for curing cerebrovascular disease and its production Download PDFInfo
- Publication number
- CN1051935C CN1051935C CN95107798A CN95107798A CN1051935C CN 1051935 C CN1051935 C CN 1051935C CN 95107798 A CN95107798 A CN 95107798A CN 95107798 A CN95107798 A CN 95107798A CN 1051935 C CN1051935 C CN 1051935C
- Authority
- CN
- China
- Prior art keywords
- grams
- radix
- capsule
- naoxuekang
- senile dementia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a naoxuekang capsule for treating senile dementia and a preparation process thereof. The naoxuekang capsule for treating senile dementia is composed of the traditional Chinese medicines: 135 to 165 grams of prepared rhizomes of rehmannia, 68 to 83 grams of tortoise plastron, 135 to 165 grams of desertliving cistanche, 68 to 83 grams of pulp of dogwood fruit, 68 to 83 grams of prepared fleece flower root, 4 to 6 grams of musk, 68 to 83 grams of radix polygalae, 81 to 99 grams of grassleaved sweetflag rhizome, 68 to 83 grams of peach kernel, 90 to 110 grams of hirudo, 90 to 110 grams of eupolyphaga, 40 to 50 grams of prepared rhubarb and 68 to 83 grams of schisandra fruit. The preparation process comprises the steps of decocting, concentrating, drying, triturating, sieving, packaging and encapsulating. The naoxuekang capsule for treating senile dementia has the functions of replenishing essence, benefiting the marrow, inducing resuscitation, benefiting intelligence, dispersing blood stasis and dredging collaterals, and has obvious curative effects on senile dementia. The naoxuekang capsule has good curative effect, rapid effect taking, and no toxic or side effect; the preparation method is simple and practical, and is favorable to production.
Description
The invention belongs to a kind of method for the treatment of the Chinese medicine of senile dementia disease and being used to prepare this Chinese medicine.
Alzheimer disease is common complaint among the elderly, frequently-occurring disease.Along with the decline of human living standard's raising, medical science applied development and birth rate, the aging of population has become worldwide trend, and existing 48 countries in 173 countries and regions, the whole world in 1985 have striden into veteran form country ranks.Though China will could be veteran form country in 2000, have the hugest in the world aging population, expect the year two thousand fifty, per 4 philtrums just have an old man.And World Health Organization (WHO) report: 10% disturbance of intelligence among the over-65s old people, wherein 1/2 takes place dull-wittedly, and with the increase at age, dull-witted sickness rate obviously rises, so dementia will become old people's epidemic diseases.Modern medicine to the treatment of primary disease based on Western medicine, with disease controlling, symptomatic treatment, it is main strengthening nursing, does not still have specific treatment so far.So the performance Chinese medicine seeks to develop new effective ways to the advantage of primary disease, has been domestic and international medical circle inquiry purpose focus.
Therefore, the objective of the invention is: a kind of Chinese medicine for the treatment of alzheimer disease is provided, has good effect, instant effect, advantage without any side effects provides a kind of straightforward procedure for preparing this medicine simultaneously.
The present invention realizes that the purpose method is that the prescription for preparing Chinese medicine of the present invention is:
Radix Rehmanniae Preparata 135-165g Carapax et Plastrum Testudinis 68-83g
Herba Cistanches 135-165g Fructus Corni 68-83g
Radix Polygoni Multiflori Preparata 68-83g Moschus 4-6g
Radix Polygalae 68-83g Rhizoma Acori Graminei 81-99g
Semen Persicae 68-83g Hirudo 90-110g
Eupolyphaga 90-110g Radix et Rhizoma Rhei (processed) 40-50g
Fructus Schisandrae Chinensis 68-83g
A kind of production preparation method of Chinese medicine of the present invention that is used for:
(1) Carapax et Plastrum Testudinis, the stir-baking in sand quench in vinegar is smashed levigation, crosses the 100-120 mesh sieve, and it is stand-by to make Tortoise Shell.
(2) with Radix Rehmanniae Preparata, Herba Cistanches, Fructus Corni, Radix Polygoni Multiflori Preparata, Radix Polygalae, Rhizoma Acori Graminei, Semen Persicae, Hirudo, eupolyphaga, Radix et Rhizoma Rhei (processed), Fructus Schisandrae Chinensis, decoct with water twice, 3 hours for the first time, 2 hours for the second time, filter merging filtrate, be concentrated into the thick paste shape, drying is worn into fine powder, gradually add the Moschus cover and grind,, incapsulate with Carapax et Plastrum Testudinis fine powder mix homogeneously.
Advantage of the present invention be preparation method simple, practical, be beneficial to production, with treatment by Chinese herbs alzheimer disease of the present invention, have good effect, instant effect, and without any side effects.According to Zhengzhou City second institute of traditional Chinese medicine 103 routine patients clinicals are verified, " diagnosis of alzheimer disease, medicine typing and the efficacy assessment standard " contrast that proposed in 88 years according to Gerontological Society of the national association of traditional Chinese medicine shows obvious effective rate 77%, total effective rate 93.2%, effect is satisfactory.
Motherland's medical science is thought, " brain being the marrow sea, marrow gather in brain ", the wither essence and blood of old people's visceral-qi loses empty, is subject to exopathogen, and phlegm-turbidity and blood stasis blood is sent out primary disease for trouble, and is clinical in the majority with simulataneous insufficiency and excessive person.The present invention is just in setting upright simultaneously, holds concurrently with the eliminating evil and method row reinforcement and elimination in combination.Radix Rehmanniae Preparata, Carapax et Plastrum Testudinis nourishing YIN and benefiting blood in the side, life essence-filling, marrow-benefitting; Herba Cistanches, Fructus Corni, Radix Polygoni Multiflori Preparata liver and kidney tonifying, Moschus, Radix Polygalae, Rhizoma Acori Graminei be open to the custom key, mind tranquilizing and the heart calming, Radix Et Rhizoma Rhei, eupolyphaga, Hirudo, Semen Persicae blood circulation promoting and blood stasis dispelling, circulation of qi promoting intestinal stasis relieving; Fructus Schisandrae Chinensis nourishing kidney arresting seminal emission, calming heart and tranquilizing mind, all medicines are played altogether, life essence-filling, marrow-benefitting, having one's ideas straightened out increases intelligence, and the merit of disperse blood stasis and dredge collateral has significant curative effect to the treatment of alzheimer disease.
The invention will be further described below in conjunction with embodiment.
Embodiment 1
Select following prescription for use:
Radix Rehmanniae Preparata 150g Carapax et Plastrum Testudinis 75g
Herba Cistanches 150g Fructus Corni 75g
Radix Polygoni Multiflori Preparata 75g Moschus 5g
Radix Polygalae 75g Rhizoma Acori Graminei 90g
Semen Persicae 75g Hirudo 100g
Eupolyphaga 100g Radix et Rhizoma Rhei (processed) 45g
Fructus Schisandrae Chinensis 75g
(1) Carapax et Plastrum Testudinis, the stir-baking in sand quench in vinegar is smashed levigation, crosses the 100-120 mesh sieve, and it is stand-by to make Tortoise Shell.
(2) with Radix Rehmanniae Preparata, Herba Cistanches, Fructus Corni, Radix Polygoni Multiflori Preparata, Radix Polygalae, Rhizoma Acori Graminei, Semen Persicae, Hirudo, eupolyphaga, Radix et Rhizoma Rhei (processed), Fructus Schisandrae Chinensis, decoct with water twice, 3 hours for the first time, 2 hours for the second time, filter merging filtrate, be concentrated into the thick paste shape, drying is worn into fine powder, adds the Moschus cover gradually and grinds, with Carapax et Plastrum Testudinis fine powder mix homogeneously, incapsulate each heavy 0.5g of capsule.Contain crude drug in whole 2.5g, usage is oral, a 3-6 grain, and a twice-daily, 3 months is a course of treatment.
Embodiment 2
Select following prescription for use:
Radix Rehmanniae Preparata 135g Carapax et Plastrum Testudinis 68g
Herba Cistanches 135g Fructus Corni 68g
Radix Polygoni Multiflori Preparata 68g Moschus 4g
Radix Polygalae 68g Rhizoma Acori Graminei 81g
Semen Persicae 68g Hirudo 90g
Eupolyphaga 90g Radix et Rhizoma Rhei (processed) 40g
Fructus Schisandrae Chinensis 68g
Press embodiment 1 described method preparation, each heavy 0.5g of capsule contains crude drug in whole 2.5g, and usage is identical.
Embodiment 3
Make up a prescription by following prescription:
Radix Rehmanniae Preparata 165g Carapax et Plastrum Testudinis 83g
Herba Cistanches 165g Fructus Corni 83g
Radix Polygoni Multiflori Preparata 83g Moschus 6g
Radix Polygalae 83g Rhizoma Acori Graminei 99g
Semen Persicae 83g Hirudo 110g
Eupolyphaga 110g Radix et Rhizoma Rhei (processed) 50g
Fructus Schisandrae Chinensis 83g
Press embodiment 1 described method preparation, each heavy 0.5g of capsule contains crude drug in whole 2.5g, and usage is identical.
Chinese medicine of the present invention, treatment to alzheimer disease has curative effect preferably, can obviously slow down symptom, and without any side effects, take, easy to carry safety, reliable, stable, through 103 routine patient's clinical observations are verified, total effective rate can reach 93.2%, and manufacture method is simple, helps making and producing.
Claims (2)
1, a kind of Chinese medicine for the treatment of senile dementia disease is characterized in that it is to be made by the raw material of following consumption:
Radix Rehmanniae Preparata 135-165g Carapax et Plastrum Testudinis 68-83g
Herba Cistanches 135-165g Fructus Corni 68-83g
Radix Polygoni Multiflori Preparata 68-83g Moschus 4-6g
Radix Polygalae 68-83g Rhizoma Acori Graminei 81-99g
Semen Persicae 68-83g Hirudo 90-110g
Eupolyphaga 90-110g Radix et Rhizoma Rhei (processed) 40-50g
Fructus Schisandrae Chinensis 68-83g
2, a kind of preparation method of Chinese medicine of treatment senile dementia disease as claimed in claim 1 is characterized in that:
(1) Carapax et Plastrum Testudinis, the stir-baking in sand quench in vinegar is smashed levigation, crosses the 100-120 mesh sieve, and it is stand-by to make Tortoise Shell;
(2) with Radix Rehmanniae Preparata, Herba Cistanches, Fructus Corni, Radix Polygoni Multiflori Preparata, Radix Polygalae, Rhizoma Acori Graminei, Semen Persicae, Hirudo, eupolyphaga, Radix et Rhizoma Rhei (processed), Fructus Schisandrae Chinensis, decoct with water twice, 3 hours for the first time, 2 hours for the second time, filter merging filtrate, be concentrated into the thick paste shape, drying is worn into fine powder, gradually add the Moschus cover and grind,, incapsulate with Carapax et Plastrum Testudinis fine powder mix homogeneously.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN95107798A CN1051935C (en) | 1995-07-28 | 1995-07-28 | Naoxuekang capsule for curing cerebrovascular disease and its production |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN95107798A CN1051935C (en) | 1995-07-28 | 1995-07-28 | Naoxuekang capsule for curing cerebrovascular disease and its production |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1123690A CN1123690A (en) | 1996-06-05 |
| CN1051935C true CN1051935C (en) | 2000-05-03 |
Family
ID=5076444
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN95107798A Expired - Fee Related CN1051935C (en) | 1995-07-28 | 1995-07-28 | Naoxuekang capsule for curing cerebrovascular disease and its production |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1051935C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100348218C (en) * | 2002-08-12 | 2007-11-14 | 庆熙大学 | Composition comprising the extract of cistanche deserticola Y.C. ma showing enhancing activity of the neurite outgrowth and neurotrophic effects |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101810814B (en) * | 2010-04-28 | 2011-08-10 | 史建钢 | Medicament for curing cerebral palsy, hyperkinetic syndrome and dementia and preparation method thereof |
| CN102058717B (en) * | 2011-01-25 | 2012-01-25 | 郭芫沅 | Chinese medicine for treating femoral head necrosis |
-
1995
- 1995-07-28 CN CN95107798A patent/CN1051935C/en not_active Expired - Fee Related
Non-Patent Citations (4)
| Title |
|---|
| 《山西中医》1994年第10卷第3期 1994.3.31 王明文，脑必复汤治疗老年痴呆32例 * |
| 《河北中医》1993年第15卷第2期 1993.2.1 冯金梅等，益灵汤治疗老年早期痴呆症50例 * |
| 《河北中医》1993年第15卷第2期 1993.2.1 冯金梅等，益灵汤治疗老年早期痴呆症50例;《湖南中医杂志》1991年第7卷第2期 1991.2.1 马凤友，还少丹治疗老年怀痴呆14例;《山西中医》1994年第10卷第3期 1994.3.31 王明文，脑必复汤治疗老年痴呆32例 * |
| 《湖南中医杂志》1991年第7卷第2期 1991.2.1 马凤友，还少丹治疗老年怀痴呆14例 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100348218C (en) * | 2002-08-12 | 2007-11-14 | 庆熙大学 | Composition comprising the extract of cistanche deserticola Y.C. ma showing enhancing activity of the neurite outgrowth and neurotrophic effects |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1123690A (en) | 1996-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1047946C (en) | Preparation for treating senile diseases | |
| CN1840149A (en) | Medicinal pill for treating cardiovascular and cerebrovascular disease and its preparing process | |
| CN1051935C (en) | Naoxuekang capsule for curing cerebrovascular disease and its production | |
| CN1082376C (en) | Pathogenic factor eliminating and healthy energy supporting anticancer medicine | |
| CN1211434A (en) | Oral liquid for resisting altitude stress and its preparation method | |
| CN1109553C (en) | Chinese-medicinal capsule for treating diabetes | |
| CN100345571C (en) | Medication for treating necrosis of femoral head and preparation method | |
| CN1895593A (en) | Medicine for treating acne and its preparation | |
| CN1025774C (en) | Special "shanhaidan" and its production method | |
| CN1299673A (en) | Preparation of cancer treating medicine capsule | |
| CN1060379C (en) | Chines medicine for treating vitiligo and preparation method thereof | |
| CN1101560A (en) | Medicine for curing encephalatrophy | |
| CN1204908C (en) | Deafness and tinnitus treating Chinese medicine and its prepn | |
| CN1290553A (en) | Capsule for tonifying kidney | |
| CN1028003C (en) | Method of preparing medicine for treatment of coronary heart disease | |
| CN1036503C (en) | Medicine for treating systemic lupus erythematosus and producing method thereof | |
| CN1130529A (en) | Aizikangfuning-Chinese patent drug for treating AIDS and preparing process thereof | |
| CN1184995C (en) | Kidney-strengthening and pregnancy assisting granule | |
| CN1068217C (en) | Traditional Chinese medicine for treating skin disease and veneral disease | |
| CN1058174C (en) | Medicine for coronary heart disease and production thereof | |
| CN1218684A (en) | Capsule for expelling stone | |
| CN1150014C (en) | Lupus erythematosus treating medicine | |
| CN1056308C (en) | Medicine for adjusting cranial nerve function | |
| CN1212156A (en) | Prescription of Chinese patent drug for curing heart disease and its production process | |
| CN1168483C (en) | Heart disease treating medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20000503 Termination date: 20120728 |